1. Home
  2. Browse Decisions
  3. HORIZON PHARMA IRELAND LIMITED v. ACTAVIS LABORATORIES, UT, INC.
 

HORIZON PHARMA IRELAND LIMITED v. ACTAVIS LABORATORIES, UT, INC.

Civil No. 14-7992 (NLH/AMD).

HORIZON PHARMA IRELAND LIMITED, et al., Plaintiffs, v. ACTAVIS LABORATORIES, UT, INC., et al., Defendants.

United States District Court, D. New Jersey.

August 17, 2016.

Attorney(s) appearing for the Case

HORIZON PHARMA IRELAND LIMITED, Plaintiff, represented by JOHN EDMUND FLAHERTY , MCCARTER & ENGLISH, LLP & RAVIN R. PATEL , MCCARTER & ENGLISH LLP.

HZNP LIMITED, Plaintiff, represented by JOHN EDMUND FLAHERTY , MCCARTER & ENGLISH, LLP & RAVIN R. PATEL , MCCARTER & ENGLISH LLP.

HORIZON PHARMA USA, INC., Plaintiff, represented by JOHN EDMUND FLAHERTY , MCCARTER & ENGLISH, LLP & RAVIN R. PATEL , MCCARTER & ENGLISH LLP.

ACTAVIS LABORATORIES, UT, INC., Defendant, represented by LIZA M. WALSH , WALSH PIZZI O'REILLY FALANGA LLP, CHRISTINE INTROMASSO GANNON , WALSH PIZZI O'REILLY FALANGA LLP & KATELYN O'REILLY , WALSH PIZZI O'REILLY FALANGA LLP.

ACTAVIS LABORATORIES, UT, INC., Counter Claimant, represented by LIZA M. WALSH , WALSH PIZZI O'REILLY FALANGA LLP & CHRISTINE INTROMASSO GANNON , WALSH PIZZI O'REILLY FALANGA LLP.

ACTAVIS, INC., Counter Claimant, represented by LIZA M. WALSH , WALSH PIZZI O'REILLY FALANGA LLP & CHRISTINE INTROMASSO GANNON , WALSH PIZZI O'REILLY FALANGA LLP.

ACTAVIS PLC, Counter Claimant, represented by LIZA M. WALSH , WALSH PIZZI O'REILLY FALANGA LLP & CHRISTINE INTROMASSO GANNON , WALSH PIZZI O'REILLY FALANGA LLP.

HORIZON PHARMA IRELAND LIMITED, Counter Defendant, represented by JOHN EDMUND FLAHERTY , MCCARTER & ENGLISH, LLP & RAVIN R. PATEL , MCCARTER & ENGLISH LLP.

HORIZON PHARMA USA, INC., Counter Defendant, represented by JOHN EDMUND FLAHERTY , MCCARTER & ENGLISH, LLP & RAVIN R. PATEL , MCCARTER & ENGLISH LLP.

HZNP LIMITED, Counter Defendant, represented by JOHN EDMUND FLAHERTY , MCCARTER & ENGLISH, LLP & RAVIN R. PATEL , MCCARTER & ENGLISH LLP.

OPINION

Presently before the Court in this Hatch-Waxman Act1 action is the dispute over the construction of claims in nine patents relating to PENNSAID® 2%, which is the first FDA-approved twicedaily topical diclofenac sodium formulation for the treatment of the pain of...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases